OPKO HEALTH, INC. (OPK)

1.44 0 (-0.06%)

As of 2025-10-28 17:11:20 EST

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

Traded asNasdaq: OPK
ISINUS68375N1037
CIK0000944809
LEI529900A4S2D4OGOJLL02
EIN752402409
Sector—
IndustryPharmaceutical Preparations
CEO—
Employees6,096
Fiscal Year End1231
Address4400 BISCAYNE BLVD., MIAMI, FL, 33137
Phone305-575-4181
Websitehttps://opko.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
OPKOPKO HEALTH, INC.2025-10-28 17:11:201.440-0.06
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
OPK0000944809OPKO HEALTH, INC.US68375N1037529900A4S2D4OGOJLL02752402409Nasdaq2834Pharmaceutical Preparations1231DE4400 BISCAYNE BLVD.MIAMIFL33137UNITED STATESUS305-575-41814400 BISCAYNE BLVD., MIAMI, FL, 331374400 BISCAYNE BLVD., MIAMI, FL, 33137EXEGENICS INC—1991—6,096https://opko.com414,913,527809,582,957793,782,780OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".2025-10-23 14:18:39
This is a preview of the latest data. Subscribe to access the full data.
OPK Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
OPK Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2024414,913,527-489,569,904-54.127671,550,270-25,441,397-3.6502
2023904,483,431-156,779,292-14.7729696,991,667-75,659,145-9.7922
20221,061,262,723-545,918,630-33.9675772,650,81291,125,63113.3708
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Steven D. RubinExecutive Vice President2020810,0000——11,2001,262,200
Adam LogalChief Financial Officer, Senior Vice President2020600,000500,000——11,2001,552,200
Phillip FrostChief Executive Officer2020960,0000——11,2001,538,200
Jane H. HsiaoChief Technical Officer2020900,0000——11,2001,478,200
Jon R. CohenExecutive Chairman, Senior Vice President2020575,0001,150,000——11,2003,491,200
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
20242,997
20233,930
20224,196
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202420232022
Revenue713,142,000863,495,0001,004,196,000
Cost Of Revenue494,632,000445,830,000627,548,000
Gross Profit218,511,000——
Research And Development Expenses105,214,00089,593,00073,887,000
General And Administrative Expenses304,220,000300,559,000372,672,000
Operating Expenses865,207,0001,020,516,0001,230,449,000
Operating Income-152,065,000-157,021,000-226,253,000
Net Income-53,224,000-188,863,000-328,405,000
Earnings Per Share Basic-0.08-0.25-0.46
Earnings Per Share Diluted0.01—-0.46
Weighted Average Shares Outstanding Basic694,019,535751,765,915719,060,942
Weighted Average Shares Outstanding Diluted-5,322,400,000—719,060,942
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202420232022
Cash And Cash Equivalents426,582,00095,881,000153,191,000
Marketable Securities Current———
Accounts Receivable118,017,000123,379,000127,312,000
Inventories56,797,00065,697,00074,060,000
Non Trade Receivables———
Other Assets Current10,705,0007,673,0006,252,000
Total Assets Current662,089,000309,476,000394,525,000
Marketable Securities Non Current54,584,00016,082,00028,080,000
Property Plant And Equipment70,134,00075,429,000—
Other Assets Non Current18,537,0009,080,0008,679,000
Total Assets Non Current1,538,123,0001,702,222,0001,772,734,000
Total Assets2,200,212,0002,011,698,0002,167,259,000
Accounts Payable47,071,00069,677,00066,993,000
Deferred Revenue6,00000
Short Term Debt14,849,00027,293,00033,540,000
Other Liabilities Current118,357,00090,086,00098,269,000
Total Liabilities Current193,096,000200,052,000213,480,000
Long Term Debt437,203,000249,345,000256,251,000
Other Liabilities Non Current32,838,00027,189,00027,371,000
Total Liabilities Non Current641,668,000422,427,000392,131,000
Total Liabilities834,764,000622,479,000605,611,000
Common Stock7,015,0007,820,0007,813,000
Retained Earnings-2,065,010,000-2,011,786,000-1,822,923,000
Accumulated Other Comprehensive Income-56,130,000-38,030,000-43,323,000
Total Shareholders Equity1,365,448,0001,389,219,0001,561,648,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202420232022
Depreciation And Amortization98,176,000105,297,000108,655,000
Share Based Compensation Expense11,048,00011,413,00018,509,000
Other Non Cash Income Expense——0
Change In Accounts Receivable220,000-3,411,000-128,602,000
Change In Inventories-4,217,000-15,197,000-13,662,000
Change In Non Trade Receivables———
Change In Other Assets-237,000288,000-1,935,000
Change In Accounts Payable-20,662,0002,828,000-9,388,000
Change In Other Liabilities—-11,559,000-90,781,000
Cash From Operating Activities-183,489,000-28,197,000-95,189,000
Purchases Of Marketable Securities05,000,0000
Sales Of Marketable Securities166,604,000364,000115,423,000
Acquisition Of Property Plant And Equipment25,010,00016,275,00024,578,000
Acquisition Of Business001,758,000
Other Investing Activities———
Cash From Investing Activities352,214,000-18,198,00091,038,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends—033,000,000
Issuance Of Common Stock———
Repurchase Of Common Stock90,223,000——
Issuance Of Long Term Debt250,000,000——
Repayment Of Long Term Debt475,061,000679,709,0001,035,774,000
Other Financing Activities———
Cash From Financing Activities184,166,000-11,303,00022,971,000
Change In Cash349,734,000-57,310,00018,481,000
Cash At End Of Period426,582,00095,881,000153,191,000
Income Taxes Paid10,008,0003,712,0008,037,000
Interest Paid20,883,0008,135,0007,420,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202420232022
Earnings Per Share-0.08-0.25-0.46
Price To Earnings Ratio-18.375-6.04-2.7174
Earnings Growth Rate-68-45.6522820
Price Earnings To Growth Ratio0.27020.1323-0.0033
Book Value Per Share1.96741.84792.1718
Price To Book Ratio0.74720.81710.5756
Ebitda102,425,000-66,348,000-199,657,000
Enterprise Value1,045,678,716.451,315,923,531.651,035,426,177.5
Dividend Yield—00.0367
Dividend Payout Ratio—0-0.1005
Debt To Equity Ratio0.33110.19910.1856
Capital Expenditures92,881,000——
Free Cash Flow-276,370,000——
Return On Equity-0.039-0.1359-0.2103
One Year Beta1.04311.41311.5114
Three Year Beta1.4161.45481.1722
Five Year Beta1.17911.23021.2418
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
FROST PHILLIP MD ET ALDirector, CEO & Chairman, 10% owner2025-08-18440,000D214,236,448
FROST PHILLIP MD ET ALDirector, CEO & Chairman, 10% owner2025-08-08675,000A214,676,448
Nabel Gary J.Director, Chief Innovation Officer2025-05-27437,500A437,500
Logal AdamSr. Vice President, CFO2025-05-27437,500A437,500
Rubin Steven DDirector, Executive VP-Administration2025-05-27437,500A437,500
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Carlos Curbelo2017-10-03FL26Purchase2017-09-26—$1,001 - $15,000
Carlos Mr Curbelo2017-03-02FL26Purchase2017-03-02—$1,001 - $15,000
Carlos Mr Curbelo2017-02-07FL26Purchase2017-02-07—$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Csenge Advisory Group2025-09-30181,352117,0011.55
MOSELEY INVESTMENT MANAGEMENT INC2025-09-3038,98625,1531.55
PBMares Wealth Management LLC2025-09-3041,88327,0211.55
HARBOR INVESTMENT ADVISORY, LLC2025-09-302791801.55
Colony Family Offices, LLC2025-09-3022,83014,7291.55
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
FIDELITY CONCORD STREET TRUST2025-08-31Fidelity Series Total Market Index FundFCFMX630,742870,423.960.001
FIDELITY CONCORD STREET TRUST2025-08-31Fidelity Total Market Index FundFSKAX934,3721,289,433.360.0011
FIDELITY CONCORD STREET TRUST2025-08-31Fidelity Nasdaq Composite Index FundFNCMX559,350771,9030.0037
FIDELITY COMMONWEALTH TRUST2025-08-31Fidelity Nasdaq Composite Index ETFONEQ287,570396,846.60.0047
FIDELITY CONCORD STREET TRUST2025-08-31Fidelity Extended Market Index FundFSMAX2,451,5133,383,087.940.0082
This is a preview of the latest data. Subscribe to access the full data.